经皮冠状动脉介入治疗急性心肌梗死的有效性及安全性评价

Evaluation of efficacy and safety of percutaneous coronary intervention in treating acute myocardial infarction

急性心肌梗死是临床中常见心血管疾病,主要表现为胸骨后疼痛症状,随着病情发展可并发休克、心力衰竭、心律失常等症状,甚至危及患者生命安全。目前针对急性心肌梗死病症主要应用药物保守治疗、溶栓治疗、经皮冠状动脉介入术(PCI)治疗等方式,而PCI已成为治疗急性心肌梗死的首选方式,对于改善患者心肌缺血症状,促进冠状动脉血液循环尽快恢复有显著作用。但PCI后发生再狭窄一直是影响术后近期与远期疗效的关键。因而在本文中,主要针对急性心肌梗死患者在实施PCI治疗情况进行分析,并进一步评价该术式应用于临床的有效性与安全性。

Acute myocardial infarction(AMI)is a common cardiovascular disease in clinical practice,the main symptom is post-sternal pain,as the disease progresses,the symptoms such as shock,heart failure and arrhythmia may be complicated,which even endangering the life of the patients.At present,the treatment of acute myocardial infarction is mainly based on conservative drug therapy,thrombolytic therapy and percutaneous coronary intervention,while percutaneous coronary intervention has become the first choice for the treatment of acute myocardial infarction,which can improve the symptoms of myocardial ischemia and promote the recovery of coronary blood circulation as soon as possible,however,the occurrence of restenosis after percutaneous coronary intervention has always been the key to affect the short-term and long-term efficacy after surgery.Therefore,this article may mainly analyze the situation of patients who undergoing percutaneous coronary intervention for acute myocardial infarction and further evaluate the effectiveness and safety of this procedure in clinical application.